Showing results (291-300 of 979) with videos related to
Sort By:
Pageof 98
Current Drug Safety|March 10, 2010
Contraindications for anticoagulation in older patients with atrial fibrillation; a narrative reviewLinda R Tulner, Ingeborg M J A Kuper, Jos P C M van Campen, et al.Current Drug Safety|March 10, 2010
Distribution of CYP2C9 and VKORC1 risk alleles for warfarin sensitivity and resistance in the Israeli populationEdna Efrati, Hela Elkin, Eli Sprecher, et al.Current Drug Safety|June 21, 2018
Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated PhacoemulsificationOlga E Makri, Iasonas K Tsekouras, Panagiotis Plotas, et al.Current Drug Safety|June 21, 2018
Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter StudyAndrea D Pratico, Laura Longo, Silvana Mansueto, et al.Current Drug Safety|May 7, 2019
Protective Effect of Edaravone on Cyclophosphamide Induced Oxidative Stress and Neurotoxicity in RatsSanjiv Singh, Abhishek KumarCurrent Drug Safety|March 18, 2022
Clinical Outcomes of Zinc Supplementation Among COVID-19 PatientsAndrew D Berti, Pramodini B Kale-Pradhan, Christopher A Giuliano, et al.Current Drug Safety|March 29, 2022
An Electronic Evaluation of Symptoms in People of India Post-COVID-19 VaccinationSweta Kamboj, Rohit Kamboj, Shikha Kamboj, et al.Current Drug Safety|March 8, 2022
A Case of Chronic HCV Infection Reactivation in a Psoriasis Patient Treated with GuselkumabMatteo Megna, Gabriella Fabbrocini, Lucia Gallo, et al.Current Drug Safety|October 2, 2019
Impact of Abuse of Topical Corticosteroids and Counterfeit Cosmetic Products for the Face: Prospective Demographic Study in Basrah City, IraqAusama Ayob Jaccob, Abdulla Ayob Yaqoub, Muataz Abdulla RahmaniCurrent Drug Safety|October 2, 2019
Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 PatientsLamiaa N Abdelaty, Ahmed A Elnaggar, Amira A Said, et al.Pageof 98